HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: A genome-wide association study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Miki, Daiki ^a,b   Ochi, Hidenori ^a,b   Takahashi, Atsushi ^a   Hayes, C Nelson ^a,b   Urabe, Yuji ^b   Abe, Hiromi ^a,b   Kawaoka, Tomokazu ^a,b   Tsuge, Masataka ^b   Hiraga, Nobuhiko ^a,b   Imamura, Michio ^a,b   Kawakami, Yoshiiku ^a,b   Aikata, Hiroshi ^a,b   Takahashi, Shoichi ^b   Akuta, Norio ^c   Suzuki, Fumitaka ^c   Ikeda, Kenji ^c   Kumada, Hiromitsu ^c   Karino, Yoshiyasu ^d   Toyota, Joji ^d   Tsunoda, Tatsuhiko ^a   Kubo, Michiaki ^a   Kamatani, Naoyuki ^a   Nakamura, Yusuke ^e   Chayama, Kazuaki ^a,b   more..

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d Sapporo Kosei General Hospital   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA-DQB1 ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEPATITIS C; HEPATITIS C VIRUS; HLA DQ GENE; HUMAN; IFNL3 GENE; IFNL4 GENE; JAPANESE; MAJOR CLINICAL STUDY; MALE; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; STATISTICAL MODEL;

ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS C, CHRONIC; HLA-DQ BETA-CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84893472976     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084226     Document Type: Article

References (36)

1. Chayama K, Hayes CN, Ohishi W, Kawakami Y (2013) Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines. J Gastroenterol 48: 1-12. doi:10.1007/s00535-012-0714-9. PubMed: 23188091.
2. Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29Suppl 1 : 74-81. doi:10.1111/j.1478-3231.2008.01702.x. PubMed: 19207969.
3. Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R et al. (1995) Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21: 639-644. doi:10.1002/hep.1840210306. PubMed: 7533121.
4. Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM et al. (2009) Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 49: 1847-1858. doi:10.1002/hep.22877. PubMed: 19434718.
5. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567. doi:10.1016/S1473-3099(05)70216- 4. PubMed: 16122679.
6. Prieto M, Olaso V, Verdú C, Córdoba J, Gisbert C et al. (1995) Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology 22: 413-417. doi: 10.1016/0270-9139(95)95374-4. PubMed: 7635408.
7. Singh R, Kaul R, Kaul A, Khan K (2007) A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 13: 1770-1787. PubMed: 17465466.
8. Kuzushita N, Hayashi N, Moribe T, Katayama K, Kanto T et al. (1998) Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology 27: 240-244. doi:10.1002/hep.510270136. PubMed: 9425943.
9. Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T et al. (2003) Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease. Tissue Antigens 61: 159-165. doi:10.1034/j.1399-0039.2003.00015.x. PubMed: 12694584.
10. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874. doi:10.1126/science.1097670. PubMed: 15297676.
11. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801. doi:10.1038/nature08463. PubMed: 19759533.
12. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, et al. (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138: 1338-1345.e7
13. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A et al. (2013) Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 158: 235-245. doi:10.7326/0003-4819-158-4-201302190-00003. PubMed: 23420232.
14. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45: 164-171. doi:10.1038/ng.2521. PubMed: 23291588.
15. Tanaka J, Kumagai J, Katayama K, Komiya Y, Mizui M et al. (2004) Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the Mart,485,648 first-time blood donors during 1995-2000. Intervirology 47: 32-40. doi:10.1159/000076640. PubMed: 15044834.
16. Bakr I, Rekacewicz C, El Hosseiny M, Ismail S, El Daly M et al. (2006) Higher clearance of hepatitis C virus infection in females compared with males. Gut 55: 1183-1187. PubMed: 16434426.
17. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K et al. (1998) Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology 27: 1394-1402. doi:10.1002/hep.510270529. PubMed: 9581697.
18. Haydon GH, Jarvis LM, Simmonds P, Harrison DJ, Garden OJ et al. (1997) Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. Gut 40: 128-132. PubMed: 9155590.
19. Kawaoka T, Hayes CN, Ohishi W, Ochi H, Maekawa T et al. (2011) Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b. J Hepatol 54: 408-414. doi:10.1016/j.jhep.2010.07.032. PubMed: 21112660.
20. Hiraga N, Imamura M, Hatakeyama T, Kitamura S, Mitsui F et al. (2009) Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice. J Hepatol 51: 1046-1054. doi:10.1016/j.jhep.2009.09.002. PubMed: 19853955.
21. Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE et al. (2004) Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 101: 1999-2004. doi:10.1073/pnas.0308458100. PubMed: 14769912.
22. Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R et al. (2011) IL-28B predicts response to chronic hepatitis C therapy - fine-mapping and replication study in Asian populations. J Gen Virol 92: 1071-1081. doi:10.1099/vir.0.029124- 0. PubMed: 21228123.
23. Chayama K, Hayes CN, Imamura M (2012) Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replication. Hepatol Res 42: 841-853. doi:10.1111/j.1872-034X.2012.01002.x. PubMed: 22524382.
24. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M et al. (2011) A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum Mol Genet 20: 3884-3892. doi: 10.1093/hmg/ddr301. PubMed: 21750111.
25. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-595. doi:10.1038/ng.348. PubMed: 19349983.
26. Jiang DK, Sun J, Cao G, Liu Y, Lin D et al. (2013) Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 45: 72-75. doi:10.1038/ng.2483. PubMed: 23242368.
27. Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R et al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43: 455-458. doi: 10.1038/ng.809. PubMed: 21499248.
28. Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y et al. (2008) Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol 69: 443-464. doi:10.1016/j.humimm.2008.05.001. PubMed: 18638659.
29. Cangussu LO, Teixeira R, Campos EF, Rampim GF, Mingoti SA et al. (2011) HLA class II alleles and chronic hepatitis C virus infection. Scand J Immunol 74: 282-287. doi:10.1111/j.1365-3083.2011.02568.x. PubMed: 21535077.
30. Nakamura Y (2007) The BioBank Japan Project. Clin Adv Hematol Oncol 5: 696-697. PubMed: 17982410.
31. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N et al. (2008) Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 83: 445-456. doi:10.1016/j.ajhg.2008.08.019. PubMed: 18817904.
32. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H et al. (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46: 471-477. doi:10.1007/s100380170047. PubMed: 11501945.
33. van der Zwan A, Griffith B, Rozemuller E, Williams T, Tilanus MGJ, Tilanus MGJ, ed. (2002) IHWG Technical Manual Genomic Analysis of the Human MHC: DNA-Based Typing for HLA Alleles and Linked Polymorphisms. Seattle: International Histocompatibility Working Group.
34. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. doi:10.1093/bioinformatics/bth457. PubMed: 15297300.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575. doi:10.1086/519795. PubMed: 17701901.
36. Menashe I, Rosenberg PS, Chen BE (2008) PGA: power calculator for case-control genetic association analyses. BMC Genet 9: 36. doi: 10.1186/1471-2350-9-36. PubMed: 18477402.